ILLUMINA INC (1ILMN.MI) Stock Fundamental Analysis

BIT:1ILMN • US4523271090

104.44 EUR
+1.24 (+1.2%)
Last: Nov 4, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Taking everything into account, 1ILMN scores 6 out of 10 in our fundamental rating. 1ILMN was compared to 18 industry peers in the Life Sciences Tools & Services industry. Both the health and profitability get an excellent rating, making 1ILMN a very profitable company, without any liquidiy or solvency issues. 1ILMN has a correct valuation and a medium growth rate. These ratings could make 1ILMN a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year 1ILMN was profitable.
  • 1ILMN had a positive operating cash flow in the past year.
  • In multiple years 1ILMN reported negative net income over the last 5 years.
  • Each year in the past 5 years 1ILMN had a positive operating cash flow.
1ILMN.MI Yearly Net Income VS EBIT VS OCF VS FCF1ILMN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

  • With an excellent Return On Assets value of 11.38%, 1ILMN belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 29.53%, 1ILMN belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
  • The Return On Invested Capital of 1ILMN (15.57%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROIC 15.57%
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1ILMN.MI Yearly ROA, ROE, ROIC1ILMN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • The Profit Margin of 1ILMN (16.39%) is better than 89.47% of its industry peers.
  • Looking at the Operating Margin, with a value of 20.41%, 1ILMN belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
  • 1ILMN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of 1ILMN (66.74%) is better than 94.74% of its industry peers.
  • 1ILMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
1ILMN.MI Yearly Profit, Operating, Gross Margins1ILMN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ILMN is still creating some value.
  • The number of shares outstanding for 1ILMN remains at a similar level compared to 1 year ago.
  • 1ILMN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1ILMN has a worse debt to assets ratio.
1ILMN.MI Yearly Shares Outstanding1ILMN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1ILMN.MI Yearly Total Debt VS Total Assets1ILMN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 4.11 indicates that 1ILMN is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.11, 1ILMN belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
  • The Debt to FCF ratio of 1ILMN is 1.99, which is an excellent value as it means it would take 1ILMN, only 1.99 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.99, 1ILMN belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
  • 1ILMN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • 1ILMN has a Debt to Equity ratio of 0.42. This is amongst the best in the industry. 1ILMN outperforms 84.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Altman-Z 4.11
ROIC/WACC1.54
WACC10.08%
1ILMN.MI Yearly LT Debt VS Equity VS FCF1ILMN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • 1ILMN has a Current Ratio of 1.43. This is a normal value and indicates that 1ILMN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.43, 1ILMN perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
  • A Quick Ratio of 1.12 indicates that 1ILMN should not have too much problems paying its short term obligations.
  • 1ILMN has a Quick ratio of 1.12. This is in the better half of the industry: 1ILMN outperforms 63.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.12
1ILMN.MI Yearly Current Assets VS Current Liabilites1ILMN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • 1ILMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.02%, which is quite impressive.
  • 1ILMN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.93% yearly.
  • 1ILMN shows a decrease in Revenue. In the last year, the revenue decreased by -2.32%.
  • The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%

3.2 Future

  • Based on estimates for the next years, 1ILMN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.99% on average per year.
  • 1ILMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.93% yearly.
EPS Next Y93.48%
EPS Next 2Y43.68%
EPS Next 3Y33.01%
EPS Next 5Y24.99%
Revenue Next Year-1.07%
Revenue Next 2Y0.57%
Revenue Next 3Y2.22%
Revenue Next 5Y3.93%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1ILMN.MI Yearly Revenue VS Estimates1ILMN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
1ILMN.MI Yearly EPS VS Estimates1ILMN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • 1ILMN is valuated quite expensively with a Price/Earnings ratio of 27.93.
  • The rest of the industry has a similar Price/Earnings ratio as 1ILMN.
  • When comparing the Price/Earnings ratio of 1ILMN to the average of the S&P500 Index (26.68), we can say 1ILMN is valued inline with the index average.
  • The Price/Forward Earnings ratio is 24.05, which indicates a rather expensive current valuation of 1ILMN.
  • 1ILMN's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. 1ILMN is around the same levels.
Industry RankSector Rank
PE 27.93
Fwd PE 24.05
1ILMN.MI Price Earnings VS Forward Price Earnings1ILMN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ILMN is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, 1ILMN is valued a bit cheaper than 73.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.7
EV/EBITDA 16.68
1ILMN.MI Per share data1ILMN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1ILMN has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1ILMN's earnings are expected to grow with 33.01% in the coming years.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y43.68%
EPS Next 3Y33.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for 1ILMN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ILLUMINA INC

BIT:1ILMN (11/4/2025, 7:00:00 PM)

104.44

+1.24 (+1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-30
Earnings (Next)02-04
Inst Owners102.96%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap16.05B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts72.86
Price Target97.42 (-6.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)3.23%
PT rev (3m)3.23%
EPS NQ rev (1m)4.77%
EPS NQ rev (3m)4.77%
EPS NY rev (1m)9.83%
EPS NY rev (3m)9.83%
Revenue NQ rev (1m)2.27%
Revenue NQ rev (3m)2.27%
Revenue NY rev (1m)1.07%
Revenue NY rev (3m)1.07%
Valuation
Industry RankSector Rank
PE 27.93
Fwd PE 24.05
P/S 4.36
P/FCF 18.7
P/OCF 16.66
P/B 7.85
P/tB 17.93
EV/EBITDA 16.68
EPS(TTM)3.74
EY3.58%
EPS(NY)4.34
Fwd EY4.16%
FCF(TTM)5.59
FCFY5.35%
OCF(TTM)6.27
OCFY6%
SpS23.95
BVpS13.3
TBVpS5.83
PEG (NY)0.3
PEG (5Y)N/A
Graham Number33.45
Profitability
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROCE 20.76%
ROIC 15.57%
ROICexc 22.34%
ROICexgc 41.04%
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
FCFM 23.32%
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Debt/EBITDA 0.86
Cap/Depr 44.36%
Cap/Sales 2.85%
Interest Coverage 250
Cash Conversion 97.57%
Profit Quality 142.25%
Current Ratio 1.43
Quick Ratio 1.12
Altman-Z 4.11
F-Score7
WACC10.08%
ROIC/WACC1.54
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y93.48%
EPS Next 2Y43.68%
EPS Next 3Y33.01%
EPS Next 5Y24.99%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-1.07%
Revenue Next 2Y0.57%
Revenue Next 3Y2.22%
Revenue Next 5Y3.93%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year30.85%
EBIT Next 3Y15.15%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%

ILLUMINA INC / 1ILMN.MI FAQ

What is the ChartMill fundamental rating of ILLUMINA INC (1ILMN.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1ILMN.MI.


Can you provide the valuation status for ILLUMINA INC?

ChartMill assigns a valuation rating of 4 / 10 to ILLUMINA INC (1ILMN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for ILLUMINA INC?

ILLUMINA INC (1ILMN.MI) has a profitability rating of 4 / 10.


What is the valuation of ILLUMINA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ILLUMINA INC (1ILMN.MI) is 27.93 and the Price/Book (PB) ratio is 7.85.